Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy

Documenti analoghi

• Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
  di: Lewis, Joanna, et al.
  Pubblicazione: (2017)
• Early limited antiretroviral therapy is superior to deferred therapy in HIV-infected South African infants: results from the CHER (Children with HIV Early antiRetroviral) Randomized Trial
  di: Cotton, Mark F, et al.
  Pubblicazione: (2013)
• Five year neurodevelopment outcomes of perinatally HIV‐infected children on early limited or deferred continuous antiretroviral therapy
  di: Laughton, Barbara, et al.
  Pubblicazione: (2018)
• Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up
  di: Violari, A, et al.
  Pubblicazione: (2012)
• A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
  di: Violari, Avy, et al.
  Pubblicazione: (2019)